| Literature DB >> 35884124 |
Neveen A Abdelaziz1, Walid F Elkhatib2,3, Mahmoud M Sherif1, Mohammed A S Abourehab4, Sara T Al-Rashood5, Wagdy M Eldehna6,7, Nada M Mostafa8, Nooran S Elleboudy2.
Abstract
Despite the mounting global burden of antimicrobial resistance (AMR), the generation of new classes of effective antimicrobials still lags far behind. The interplay between multidrug resistance and biofilm formation in Acinetobacter baumannii has drastically narrowed the available therapeutic choices. The use of natural compounds holds promise as an alternate option for restoring the activity of existing antibiotics and attenuating virulence traits through reduced biofilm formation. This study aimed to evaluate the modulatory effect of combining cinnamic and gallic acids at ½MIC with various antibiotics against multidrug-resistant (MDR) A. baumannii clinical isolates as well as study the effect on the expression of the biofilm-associated genes (bap, csuE, ompA) via quantitative, real-time PCR. Combining cinnamic or gallic acid with imipenem, amikacin or doxycycline resulted in significant reduction of resistance (p < 0.05). On the contrary, no effect was recorded when both acids were combined with levofloxacin, and only cinnamic acid had a synergistic effect with colistin. The transcriptomic changes of biofilm-related genes in the presence of gallic acid at ½MIC were compared with untreated control samples. The fold expression values proved that gallic acid substantially down-regulated the respective genes in all five strong biofilm formers. Molecular docking studies of gallic and cinnamic acids on target genes revealed good binding affinities and verified the proposed mechanism of action. To the best of our knowledge, this is the first report on the effect of gallic acid on the expression of bap, csuE and ompA genes in A. baumannii, which may permit its use as an adjunct anti-virulence therapeutic strategy.Entities:
Keywords: Acinetobacter baumannii; biofilm; cinnamic acid; gallic acid; resistance modulation
Year: 2022 PMID: 35884124 PMCID: PMC9311515 DOI: 10.3390/antibiotics11070870
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
Figure 1Violin plots showing MICs of the selected 30 MDR isolates against (A) amikacin, (B) colisitin, (C) doxycycline, (D) imipenem and (E) levofloxacin in presence/absence of cinnamic or gallic acids. p-values, **: p < 0.01, ***: p < 0.001, ****: p < 0.0001, ns: not significant (p > 0.05).
Figure 2Relative expression of (A) bap, (B) csuE and (C) ompA genes in presence of gallic acid at ½MIC compared with untreated control samples.
Figure 3Bacterial growth curve of the five selected biofilm-forming A. baumannii isolates (A–E) in the presence of ½MIC of gallic acid along with the untreated growth controls.
Figure 4Binding diagrams of gallic (A,B) and cinnamic (C,D) acid into the active sites of CsuE protein.
Figure 5Binding diagrams of gallic (A,B) and cinnamic (C,D) acid into the active sites of OmpA protein.
Resistance profiles of the 30 MDR clinical Acinetobacter baumannii isolates.
| Antibiotic | Number of Resistant Isolates (%) |
|---|---|
| Levofloxacin | 30 (100) |
| Imipenem | 28 (93.3) |
| Amikacin | 28 (93.3) |
| Doxycycline | 27 (90) |
| Colistin | 6 (20) |
Primer sequences for the genes evaluated.
| Gene | Primer | |
|---|---|---|
|
| Forward | TGCTGACAGTGACGTAGAACCACA |
|
| Forward | CATCTTCTATTTCGGTCCC |
|
| Forward | GTTAAAGGCGACGTAGACG |
| 16S rRNA | Forward | ACCGTCAAGGGACAAGCA |